435 Epigenetic Activation of a Novel TGFβ2 Enhancer Sustains Dermal Fibrosis in Systemic Sclerosis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.511
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

Angiotensin II Induces Skin Fibrosis: A Novel Mouse Model of Dermal Fibrosis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

AB0182 in Vitro Characterization of Dermal Fibroblasts From Systemic Sclerosis Patients

2017English

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances

Frontiers in Immunology
AllergyImmunology
2018English

High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis

PLoS ONE
Multidisciplinary
2014English

Semaphorin4A Coordinately Induces Inflammation and Fibrosis in Systemic Sclerosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

P119 Epigenetic Regulation of WNT Signaling in Systemic Sclerosis via sFRP1

2019English

548 Inhibitory Regulation of MFG-E8 on Fibrosis in Systemic Sclerosis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

FRI0419 Intravenous Immunoglobulins Prevents Experimental Fibrosis in a Murine Model of Systemic Sclerosis

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy